_id
69131618ccc777a4e85d807f
Ticker
MGTX
Name
MeiraGTx Holdings PLC
Exchange
NASDAQ
Address
655 Third Avenue, New York, NY, United States, 10017
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://meiragtx.com
Description
MeiraGTx Holdings plc, a clinical stage genetics medicines company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases; neurodegenerative diseases; and xerostomia. It is also developing AAV-AQP1 in Phase 2 trial for radiation-induced grade 2/3 radiation-induced xerostomia, as well as in Phase ½ trial for Sjogren's syndrome; AAV-GAD in Phase 2 trial for Parkinson's disease; AAV-RPE65 in Phase 2 trial for RPE65-associated retinal dystrophy; and AAV-CNGB3 and AAV-CNGA3, which are both in Phase 2 trial for achromatopsia, as well as offers AAV-AIPL1 for Leber congenital amaurosis (LCA) 4. In addition, the company's products under preclinical development include AAV-RDH12 for retinol dehydrogenase 12 mutation-associated retinal dystrophy; AAV-BBS10 for Bardet-Biedl syndrome (BBS) due to BBS10 mutations; AAV-RetGC for LCA type 1; and AAV-UPF1 for amyotrophic lateral sclerosis, as well as programs for Alzheimer's disease, and wet and dry neovascular age related macular degeneration. Further, it provides riboswitch platform for the delivery of metabolic peptides; and cell therapies for oncology, autoimmune disease, and long term intractable pain. The company has collaborations with Johnson & Johnson Innovative Medicine for the research, development, and commercialization of gene therapies for the treatment of inherited retinal disease; and Hologen Limited for the research, development, manufacture, and commercialization of AAV-GAD investigational gene therapy for the treatment of Parkinson's disease, AAV-BDNF investigational gene therapy for genetic obesity disorders, and other genetic medicines to the central nervous system. MeiraGTx Holdings plc was founded in 2015 and is based in New York, New York.
Last Close
8.9
Volume
434619
Current Price
8.46
Change
-4.943820224719095
Last Updated
2025-12-02T11:49:02.226Z
Image
-
Ipo Date
2018-06-08T00:00:00.000Z
Market Cap
631048576
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.8181428571428572
Sentiment Sources
7
Rating
4.6
Target Price
27.5
Strong Buy
3
Buy
2
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
410000
Cost Of Revenue
313000
Gross Profit
97000
Operating Expenses
46148000
Operating Income
-46051000
Interest Expense
3065000
Pretax Income
-50513000
Net Income
-50513000
Eps
-0.6240201775706965
Dividends Per Share
-
Shares Outstanding
80490889
Income Tax Expense
-
EBITDA
-44010000
Operating Margin
-11231.951219512195
Total Other Income Expense Net
-4462000
Cash
14841000
Short Term Investments
-
Receivables
11810000
Inventories
0
Total Current Assets
34174000
Property Plant Equipment
144519000
Total Assets
189471000
Payables
21537000
Short Term Debt
76530000
Long Term Debt
-
Total Liabilities
230028000
Equity
-40557000
Depreciation
3438000
Change In Working Capital
29981000
Cash From Operations
-12215000
Capital Expenditures
610000
Cash From Investing
-547000
Cash From Financing
-219000
Net Change In Cash
-17318000
PE
-
PB
-16.885311225682372
ROE
124.54816677762162
ROA
-26.660016572456996
FCF
-12825000
Fcf Percent
-31.28048780487805
Piotroski FScore
1
Health Score
31
Deep Value Investing Score
0.5
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
6.3
Garp Investing Score
2.5
Growth Investing Score
2.5
Momentum Investing Score
4
Net Net Investing Score
0.5
Quality Investing Score
2.5
Value Investing Score
2.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
410000
Quarters > 0 > income Statement > cost Of Revenue
313000
Quarters > 0 > income Statement > gross Profit
97000
Quarters > 0 > income Statement > operating Expenses
46148000
Quarters > 0 > income Statement > operating Income
-46051000
Quarters > 0 > income Statement > interest Expense
3065000
Quarters > 0 > income Statement > pretax Income
-50513000
Quarters > 0 > income Statement > net Income
-50513000
Quarters > 0 > income Statement > eps
-0.6240201775706965
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
80947703
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-44010000
Quarters > 0 > income Statement > operating Margin
-11231.951219512195
Quarters > 0 > income Statement > total Other Income Expense Net
-4462000
Quarters > 0 > balance Sheet > cash
14841000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
11810000
Quarters > 0 > balance Sheet > inventories
0
Quarters > 0 > balance Sheet > total Current Assets
34174000
Quarters > 0 > balance Sheet > property Plant Equipment
144519000
Quarters > 0 > balance Sheet > total Assets
189471000
Quarters > 0 > balance Sheet > payables
21537000
Quarters > 0 > balance Sheet > short Term Debt
76530000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
230028000
Quarters > 0 > balance Sheet > equity
-40557000
Quarters > 0 > cash Flow > net Income
-50513000
Quarters > 0 > cash Flow > depreciation
3438000
Quarters > 0 > cash Flow > change In Working Capital
29981000
Quarters > 0 > cash Flow > cash From Operations
-12215000
Quarters > 0 > cash Flow > capital Expenditures
610000
Quarters > 0 > cash Flow > cash From Investing
-547000
Quarters > 0 > cash Flow > cash From Financing
-219000
Quarters > 0 > cash Flow > net Change In Cash
-17318000
Quarters > 0 > ratios > PE
-0.6240201775706965
Quarters > 0 > ratios > PB
-16.885311225682372
Quarters > 0 > ratios > ROE
124.54816677762162
Quarters > 0 > ratios > ROA
-26.660016572456996
Quarters > 0 > ratios > FCF
-12825000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-31.28048780487805
Quarters > 0 > health Score
31
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
3691000
Quarters > 1 > income Statement > cost Of Revenue
2676000
Quarters > 1 > income Statement > gross Profit
1015000
Quarters > 1 > income Statement > operating Expenses
45808000
Quarters > 1 > income Statement > operating Income
-44793000
Quarters > 1 > income Statement > interest Expense
3034000
Quarters > 1 > income Statement > pretax Income
-38795000
Quarters > 1 > income Statement > net Income
-38795000
Quarters > 1 > income Statement > eps
-0.4814134034450933
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
80585625
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-32571000
Quarters > 1 > income Statement > operating Margin
-1213.5735573015443
Quarters > 1 > income Statement > total Other Income Expense Net
5998000
Quarters > 1 > balance Sheet > cash
32166000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
6791000
Quarters > 1 > balance Sheet > inventories
314000
Quarters > 1 > balance Sheet > total Current Assets
47084000
Quarters > 1 > balance Sheet > property Plant Equipment
140790000
Quarters > 1 > balance Sheet > total Assets
198716000
Quarters > 1 > balance Sheet > payables
25586000
Quarters > 1 > balance Sheet > short Term Debt
2647000
Quarters > 1 > balance Sheet > long Term Debt
73773000
Quarters > 1 > balance Sheet > total Liabilities
195756000
Quarters > 1 > balance Sheet > equity
2960000
Quarters > 1 > cash Flow > net Income
-38795000
Quarters > 1 > cash Flow > depreciation
3190000
Quarters > 1 > cash Flow > change In Working Capital
-5486000
Quarters > 1 > cash Flow > cash From Operations
-43947000
Quarters > 1 > cash Flow > capital Expenditures
1234000
Quarters > 1 > cash Flow > cash From Investing
-761000
Quarters > 1 > cash Flow > cash From Financing
5450000
Quarters > 1 > cash Flow > net Change In Cash
-34186000
Quarters > 1 > ratios > PE
-0.4814134034450933
Quarters > 1 > ratios > PB
230.32242820945947
Quarters > 1 > ratios > ROE
-1310.6418918918919
Quarters > 1 > ratios > ROA
-19.522836611042894
Quarters > 1 > ratios > FCF
-45181000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-12.240856136548361
Quarters > 1 > health Score
8
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
1926000
Quarters > 2 > income Statement > cost Of Revenue
1378000
Quarters > 2 > income Statement > gross Profit
548000
Quarters > 2 > income Statement > operating Expenses
42144000
Quarters > 2 > income Statement > operating Income
-41596000
Quarters > 2 > income Statement > interest Expense
3043000
Quarters > 2 > income Statement > pretax Income
-39981000
Quarters > 2 > income Statement > net Income
-39981000
Quarters > 2 > income Statement > eps
-0.5058815099504644
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
79032341
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-33857000
Quarters > 2 > income Statement > operating Margin
-2159.709241952233
Quarters > 2 > income Statement > total Other Income Expense Net
1615000
Quarters > 2 > balance Sheet > cash
66523000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
5225000
Quarters > 2 > balance Sheet > inventories
607000
Quarters > 2 > balance Sheet > total Current Assets
79889000
Quarters > 2 > balance Sheet > property Plant Equipment
133484000
Quarters > 2 > balance Sheet > total Assets
224014000
Quarters > 2 > balance Sheet > payables
20290000
Quarters > 2 > balance Sheet > short Term Debt
3297000
Quarters > 2 > balance Sheet > long Term Debt
73495000
Quarters > 2 > balance Sheet > total Liabilities
190915000
Quarters > 2 > balance Sheet > equity
33099000
Quarters > 2 > cash Flow > net Income
-39981000
Quarters > 2 > cash Flow > depreciation
3081000
Quarters > 2 > cash Flow > change In Working Capital
-49000
Quarters > 2 > cash Flow > cash From Operations
-36828000
Quarters > 2 > cash Flow > capital Expenditures
1710000
Quarters > 2 > cash Flow > cash From Investing
-1710000
Quarters > 2 > cash Flow > cash From Financing
1713000
Quarters > 2 > cash Flow > net Change In Cash
-37058000
Quarters > 2 > ratios > PE
-0.5058815099504644
Quarters > 2 > ratios > PB
20.200417077857338
Quarters > 2 > ratios > ROE
-120.79216894770235
Quarters > 2 > ratios > ROA
-17.847545242708048
Quarters > 2 > ratios > FCF
-38538000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-20.009345794392523
Quarters > 2 > health Score
9
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
21390000
Quarters > 3 > income Statement > cost Of Revenue
11806000
Quarters > 3 > income Statement > gross Profit
9584000
Quarters > 3 > income Statement > operating Expenses
41074000
Quarters > 3 > income Statement > operating Income
-31490000
Quarters > 3 > income Statement > interest Expense
3411000
Quarters > 3 > income Statement > pretax Income
-39399000
Quarters > 3 > income Statement > net Income
-39399000
Quarters > 3 > income Statement > eps
-0.5642748819994652
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
69822353
Quarters > 3 > income Statement > income Tax Expense
-3231724
Quarters > 3 > income Statement > EBITDA
-33064000
Quarters > 3 > income Statement > operating Margin
-147.21832632071062
Quarters > 3 > income Statement > total Other Income Expense Net
-7909000
Quarters > 3 > balance Sheet > cash
103659000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
10628000
Quarters > 3 > balance Sheet > inventories
385000
Quarters > 3 > balance Sheet > total Current Assets
123518000
Quarters > 3 > balance Sheet > property Plant Equipment
135652000
Quarters > 3 > balance Sheet > total Assets
269751000
Quarters > 3 > balance Sheet > payables
23586000
Quarters > 3 > balance Sheet > short Term Debt
4053000
Quarters > 3 > balance Sheet > long Term Debt
73221000
Quarters > 3 > balance Sheet > total Liabilities
201924000
Quarters > 3 > balance Sheet > equity
67827000
Quarters > 3 > cash Flow > net Income
-39399000
Quarters > 3 > cash Flow > depreciation
2924000
Quarters > 3 > cash Flow > change In Working Capital
1453000
Quarters > 3 > cash Flow > cash From Operations
-23276000
Quarters > 3 > cash Flow > capital Expenditures
1218000
Quarters > 3 > cash Flow > cash From Investing
-1218000
Quarters > 3 > cash Flow > cash From Financing
4244000
Quarters > 3 > cash Flow > net Change In Cash
-19361000
Quarters > 3 > ratios > PE
-0.5642748819994652
Quarters > 3 > ratios > PB
8.708878564288558
Quarters > 3 > ratios > ROE
-58.08748728382503
Quarters > 3 > ratios > ROA
-14.605691915877978
Quarters > 3 > ratios > FCF
-24494000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-1.1451145395044413
Quarters > 3 > health Score
13
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
33279000
Annuals > 0 > income Statement > cost Of Revenue
23791000
Annuals > 0 > income Statement > gross Profit
9488000
Annuals > 0 > income Statement > operating Expenses
173700000
Annuals > 0 > income Statement > operating Income
-164212000
Annuals > 0 > income Statement > interest Expense
13272000
Annuals > 0 > income Statement > pretax Income
-147791000
Annuals > 0 > income Statement > net Income
-147791000
Annuals > 0 > income Statement > eps
-2.1166717197284943
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
69822353
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-121691000
Annuals > 0 > income Statement > operating Margin
-493.4403077015535
Annuals > 0 > income Statement > total Other Income Expense Net
16421000
Annuals > 0 > balance Sheet > cash
103659000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
10628000
Annuals > 0 > balance Sheet > inventories
385000
Annuals > 0 > balance Sheet > total Current Assets
123518000
Annuals > 0 > balance Sheet > property Plant Equipment
135652000
Annuals > 0 > balance Sheet > total Assets
269751000
Annuals > 0 > balance Sheet > payables
23586000
Annuals > 0 > balance Sheet > short Term Debt
4053000
Annuals > 0 > balance Sheet > long Term Debt
73221000
Annuals > 0 > balance Sheet > total Liabilities
201924000
Annuals > 0 > balance Sheet > equity
67827000
Annuals > 0 > cash Flow > net Income
-147791000
Annuals > 0 > cash Flow > depreciation
12681000
Annuals > 0 > cash Flow > change In Working Capital
29643000
Annuals > 0 > cash Flow > cash From Operations
-104495000
Annuals > 0 > cash Flow > capital Expenditures
4955000
Annuals > 0 > cash Flow > cash From Investing
23479000
Annuals > 0 > cash Flow > cash From Financing
54534000
Annuals > 0 > cash Flow > net Change In Cash
-24981000
Annuals > 0 > ratios > PE
-2.1166717197284943
Annuals > 0 > ratios > PB
8.070639236882068
Annuals > 0 > ratios > ROE
-217.89405399029883
Annuals > 0 > ratios > ROA
-54.787934057705066
Annuals > 0 > ratios > FCF
-109450000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-3.2888608431743744
Annuals > 0 > health Score
12
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
14017000
Annuals > 1 > income Statement > cost Of Revenue
13730000
Annuals > 1 > income Statement > gross Profit
14017000
Annuals > 1 > income Statement > operating Expenses
151078000
Annuals > 1 > income Statement > operating Income
-137061000
Annuals > 1 > income Statement > interest Expense
13245000
Annuals > 1 > income Statement > pretax Income
-84027000
Annuals > 1 > income Statement > net Income
-84027000
Annuals > 1 > income Statement > eps
-1.4875583158992345
Annuals > 1 > income Statement > dividends Per Share
0
Annuals > 1 > income Statement > shares Outstanding
56486525
Annuals > 1 > income Statement > income Tax Expense
13562105
Annuals > 1 > income Statement > EBITDA
-57052000
Annuals > 1 > income Statement > operating Margin
-977.8197902546907
Annuals > 1 > income Statement > total Other Income Expense Net
53034000
Annuals > 1 > balance Sheet > cash
129566000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
23415000
Annuals > 1 > balance Sheet > inventories
0
Annuals > 1 > balance Sheet > total Current Assets
159622000
Annuals > 1 > balance Sheet > property Plant Equipment
156238000
Annuals > 1 > balance Sheet > total Assets
326744000
Annuals > 1 > balance Sheet > payables
16042000
Annuals > 1 > balance Sheet > short Term Debt
4193000
Annuals > 1 > balance Sheet > long Term Debt
72119000
Annuals > 1 > balance Sheet > total Liabilities
188567000
Annuals > 1 > balance Sheet > equity
138177000
Annuals > 1 > cash Flow > net Income
-84027000
Annuals > 1 > cash Flow > depreciation
13724000
Annuals > 1 > cash Flow > change In Working Capital
-983000
Annuals > 1 > cash Flow > cash From Operations
-105365000
Annuals > 1 > cash Flow > capital Expenditures
20174000
Annuals > 1 > cash Flow > cash From Investing
34034000
Annuals > 1 > cash Flow > cash From Financing
84023000
Annuals > 1 > cash Flow > net Change In Cash
15133000
Annuals > 1 > ratios > PE
-1.4875583158992345
Annuals > 1 > ratios > PB
3.204978802550352
Annuals > 1 > ratios > ROE
-60.81113354610391
Annuals > 1 > ratios > ROA
-25.71646304140244
Annuals > 1 > ratios > FCF
-125539000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-8.956196047656418
Annuals > 1 > health Score
19
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
15920000
Annuals > 2 > income Statement > cost Of Revenue
8723000
Annuals > 2 > income Statement > gross Profit
15920000
Annuals > 2 > income Statement > operating Expenses
132275000
Annuals > 2 > income Statement > operating Income
-116355000
Annuals > 2 > income Statement > interest Expense
4946000
Annuals > 2 > income Statement > pretax Income
-129615000
Annuals > 2 > income Statement > net Income
-129615000
Annuals > 2 > income Statement > eps
-2.868993985261408
Annuals > 2 > income Statement > dividends Per Share
69969000
Annuals > 2 > income Statement > shares Outstanding
45177857
Annuals > 2 > income Statement > income Tax Expense
13260000
Annuals > 2 > income Statement > EBITDA
-116066000
Annuals > 2 > income Statement > operating Margin
-730.8731155778895
Annuals > 2 > income Statement > total Other Income Expense Net
-13260000
Annuals > 2 > balance Sheet > cash
115516000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
29023000
Annuals > 2 > balance Sheet > inventories
8133000
Annuals > 2 > balance Sheet > total Current Assets
154339000
Annuals > 2 > balance Sheet > property Plant Equipment
154093000
Annuals > 2 > balance Sheet > total Assets
318237000
Annuals > 2 > balance Sheet > payables
16616000
Annuals > 2 > balance Sheet > short Term Debt
3884000
Annuals > 2 > balance Sheet > long Term Debt
71295000
Annuals > 2 > balance Sheet > total Liabilities
200499000
Annuals > 2 > balance Sheet > equity
117738000
Annuals > 2 > cash Flow > net Income
-129615000
Annuals > 2 > cash Flow > depreciation
8603000
Annuals > 2 > cash Flow > change In Working Capital
9621000
Annuals > 2 > cash Flow > cash From Operations
-73098000
Annuals > 2 > cash Flow > capital Expenditures
44963000
Annuals > 2 > cash Flow > cash From Investing
-44963000
Annuals > 2 > cash Flow > cash From Financing
95200000
Annuals > 2 > cash Flow > net Change In Cash
-22187000
Annuals > 2 > ratios > PE
-2.868993985261408
Annuals > 2 > ratios > PB
3.0083269537447554
Annuals > 2 > ratios > ROE
-110.08765224481476
Annuals > 2 > ratios > ROA
-40.72907927110927
Annuals > 2 > ratios > FCF
-118061000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-7.415891959798995
Annuals > 2 > health Score
20
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
37701000
Annuals > 3 > income Statement > cost Of Revenue
7873000
Annuals > 3 > income Statement > gross Profit
37701000
Annuals > 3 > income Statement > operating Expenses
110459000
Annuals > 3 > income Statement > operating Income
-72758000
Annuals > 3 > income Statement > interest Expense
288000
Annuals > 3 > income Statement > pretax Income
-79561000
Annuals > 3 > income Statement > net Income
-79561000
Annuals > 3 > income Statement > eps
-1.8024835037790847
Annuals > 3 > income Statement > dividends Per Share
0
Annuals > 3 > income Statement > shares Outstanding
44139655
Annuals > 3 > income Statement > income Tax Expense
-7585000
Annuals > 3 > income Statement > EBITDA
-71400000
Annuals > 3 > income Statement > operating Margin
-192.98692342378186
Annuals > 3 > income Statement > total Other Income Expense Net
-6803000
Annuals > 3 > balance Sheet > cash
137703000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
35018000
Annuals > 3 > balance Sheet > inventories
8102000
Annuals > 3 > balance Sheet > total Current Assets
183243000
Annuals > 3 > balance Sheet > property Plant Equipment
126287000
Annuals > 3 > balance Sheet > total Assets
320164000
Annuals > 3 > balance Sheet > payables
15348000
Annuals > 3 > balance Sheet > short Term Debt
3374000
Annuals > 3 > balance Sheet > long Term Debt
953000
Annuals > 3 > balance Sheet > total Liabilities
134763000
Annuals > 3 > balance Sheet > equity
185401000
Annuals > 3 > cash Flow > net Income
-79561000
Annuals > 3 > cash Flow > depreciation
7873000
Annuals > 3 > cash Flow > change In Working Capital
31277000
Annuals > 3 > cash Flow > cash From Operations
-10530000
Annuals > 3 > cash Flow > capital Expenditures
55217000
Annuals > 3 > cash Flow > cash From Investing
-61717000
Annuals > 3 > cash Flow > cash From Financing
1708000
Annuals > 3 > cash Flow > net Change In Cash
-71817000
Annuals > 3 > ratios > PE
-1.8024835037790847
Annuals > 3 > ratios > PB
1.866521190284842
Annuals > 3 > ratios > ROE
-42.912929272226144
Annuals > 3 > ratios > ROA
-24.850076835621742
Annuals > 3 > ratios > FCF
-65747000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-1.7439059971884034
Annuals > 3 > health Score
30
Valuation > metrics > PE
-0.6240201775706965
Valuation > metrics > PB
-16.885311225682372
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
124.54816677762162
Profitability > metrics > ROA
-147.81120149821504
Profitability > metrics > Net Margin
-123.20243902439024
Profitability > final Score
40
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-15.024796084828711
Risk > final Score
-30
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.34847604188972847
Liquidity > metrics > Quick Ratio
0.34847604188972847
Liquidity > final Score
27
Liquidity > verdict
Weak
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-53
Prev Risks > 1
-49
Prev Risks > 2
-19
Prev Liquidities > 0
92
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-16T22:59:46.164Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-12
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-0.368
Earnings History > 0 > eps Difference
0.368
Earnings History > 0 > surprise Percent
100
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-13
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.62
Earnings History > 1 > eps Estimate
-0.5
Earnings History > 1 > eps Difference
-0.12
Earnings History > 1 > surprise Percent
-24
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-14
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.48
Earnings History > 2 > eps Estimate
-0.4733
Earnings History > 2 > eps Difference
-0.0067
Earnings History > 2 > surprise Percent
-1.4156
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-07
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.51
Earnings History > 3 > eps Estimate
-0.5
Earnings History > 3 > eps Difference
-0.01
Earnings History > 3 > surprise Percent
-2
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-03-12
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.5
Earnings History > 4 > eps Estimate
-0.56
Earnings History > 4 > eps Difference
0.06
Earnings History > 4 > surprise Percent
10.7143
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-12
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.55
Earnings History > 5 > eps Estimate
-0.52
Earnings History > 5 > eps Difference
-0.03
Earnings History > 5 > surprise Percent
-5.7692
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-12
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.76
Earnings History > 6 > eps Estimate
-0.4
Earnings History > 6 > eps Difference
-0.36
Earnings History > 6 > surprise Percent
-90
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-09
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.32
Earnings History > 7 > eps Estimate
-0.5
Earnings History > 7 > eps Difference
0.18
Earnings History > 7 > surprise Percent
36
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-03-14
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.42
Earnings History > 8 > eps Estimate
-0.11
Earnings History > 8 > eps Difference
-0.31
Earnings History > 8 > surprise Percent
-281.8182
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-14
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.74
Earnings History > 9 > eps Estimate
-0.55
Earnings History > 9 > eps Difference
-0.19
Earnings History > 9 > surprise Percent
-34.5455
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-10
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.53
Earnings History > 10 > eps Estimate
-0.57
Earnings History > 10 > eps Difference
0.04
Earnings History > 10 > surprise Percent
7.0175
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-05-11
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.62
Earnings History > 11 > eps Estimate
-0.66
Earnings History > 11 > eps Difference
0.04
Earnings History > 11 > surprise Percent
6.0606
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-03-14
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.6
Earnings History > 12 > eps Estimate
-0.49
Earnings History > 12 > eps Difference
-0.11
Earnings History > 12 > surprise Percent
-22.449
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-10
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.83
Earnings History > 13 > eps Estimate
-0.58
Earnings History > 13 > eps Difference
-0.25
Earnings History > 13 > surprise Percent
-43.1034
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-11
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.76
Earnings History > 14 > eps Estimate
-0.64
Earnings History > 14 > eps Difference
-0.12
Earnings History > 14 > surprise Percent
-18.75
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-05-12
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.7
Earnings History > 15 > eps Estimate
-0.52
Earnings History > 15 > eps Difference
-0.18
Earnings History > 15 > surprise Percent
-34.6154
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-03-10
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.22
Earnings History > 16 > eps Estimate
-0.51
Earnings History > 16 > eps Difference
0.29
Earnings History > 16 > surprise Percent
56.8627
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-11-10
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.59
Earnings History > 17 > eps Estimate
-0.51
Earnings History > 17 > eps Difference
-0.08
Earnings History > 17 > surprise Percent
-15.6863
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-08-11
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
BeforeMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.46
Earnings History > 18 > eps Estimate
-0.54
Earnings History > 18 > eps Difference
0.08
Earnings History > 18 > surprise Percent
14.8148
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-05-11
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
BeforeMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.54
Earnings History > 19 > eps Estimate
-0.42
Earnings History > 19 > eps Difference
-0.12
Earnings History > 19 > surprise Percent
-28.5714
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2021-03-11
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
BeforeMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.25
Earnings History > 20 > eps Estimate
-0.35
Earnings History > 20 > eps Difference
0.1
Earnings History > 20 > surprise Percent
28.5714
Earnings History > 21 > period
2020-09-30
Earnings History > 21 > report Date
2020-11-05
Earnings History > 21 > date
2020-09-30
Earnings History > 21 > before After Market
BeforeMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.17
Earnings History > 21 > eps Estimate
-0.7
Earnings History > 21 > eps Difference
0.53
Earnings History > 21 > surprise Percent
75.7143
Earnings History > 22 > period
2020-06-30
Earnings History > 22 > report Date
2020-08-06
Earnings History > 22 > date
2020-06-30
Earnings History > 22 > before After Market
BeforeMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.69
Earnings History > 22 > eps Estimate
-0.46
Earnings History > 22 > eps Difference
-0.23
Earnings History > 22 > surprise Percent
-50
Earnings History > 23 > period
2020-03-31
Earnings History > 23 > report Date
2020-05-07
Earnings History > 23 > date
2020-03-31
Earnings History > 23 > before After Market
AfterMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.43
Earnings History > 23 > eps Estimate
-0.48
Earnings History > 23 > eps Difference
0.05
Earnings History > 23 > surprise Percent
10.4167
Earnings History > 24 > period
2019-12-31
Earnings History > 24 > report Date
2020-03-11
Earnings History > 24 > date
2019-12-31
Earnings History > 24 > before After Market
AfterMarket
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.12
Earnings History > 24 > eps Estimate
-0.51
Earnings History > 24 > eps Difference
0.39
Earnings History > 24 > surprise Percent
76.4706
Earnings History > 25 > period
2019-09-30
Earnings History > 25 > report Date
2019-11-07
Earnings History > 25 > date
2019-09-30
Earnings History > 25 > before After Market
BeforeMarket
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-0.3
Earnings History > 25 > eps Estimate
-0.52
Earnings History > 25 > eps Difference
0.22
Earnings History > 25 > surprise Percent
42.3077
Earnings History > 26 > period
2019-06-30
Earnings History > 26 > report Date
2019-08-07
Earnings History > 26 > date
2019-06-30
Earnings History > 26 > before After Market
BeforeMarket
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-0.63
Earnings History > 26 > eps Estimate
-0.16
Earnings History > 26 > eps Difference
-0.47
Earnings History > 26 > surprise Percent
-293.75
Earnings History > 27 > period
2019-03-31
Earnings History > 27 > report Date
2019-05-14
Earnings History > 27 > date
2019-03-31
Earnings History > 27 > before After Market
BeforeMarket
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
-0.62
Earnings History > 27 > eps Estimate
-0.64
Earnings History > 27 > eps Difference
0.02
Earnings History > 27 > surprise Percent
3.125
Earnings History > 28 > period
2018-12-31
Earnings History > 28 > report Date
2019-03-26
Earnings History > 28 > date
2018-12-31
Earnings History > 28 > before After Market
AfterMarket
Earnings History > 28 > currency
USD
Earnings History > 28 > eps Actual
-0.58
Earnings History > 28 > eps Estimate
-0.63
Earnings History > 28 > eps Difference
0.05
Earnings History > 28 > surprise Percent
7.9365
Earnings History > 29 > period
2018-09-30
Earnings History > 29 > report Date
2018-11-08
Earnings History > 29 > date
2018-09-30
Earnings History > 29 > before After Market
BeforeMarket
Earnings History > 29 > currency
USD
Earnings History > 29 > eps Actual
-0.59
Earnings History > 29 > eps Estimate
-0.58
Earnings History > 29 > eps Difference
-0.01
Earnings History > 29 > surprise Percent
-1.7241
Earnings History > 30 > period
2018-06-30
Earnings History > 30 > report Date
2018-08-08
Earnings History > 30 > date
2018-06-30
Earnings History > 30 > before After Market
BeforeMarket
Earnings History > 30 > currency
USD
Earnings History > 30 > eps Actual
-2.2
Earnings History > 30 > eps Estimate
-0.58
Earnings History > 30 > eps Difference
-1.62
Earnings History > 30 > surprise Percent
-279.3103
Earnings History > 31 > period
2018-03-31
Earnings History > 31 > report Date
2018-06-08
Earnings History > 31 > date
2018-03-31
Earnings History > 31 > before After Market
AfterMarket
Earnings History > 31 > currency
USD
Earnings History > 31 > eps Actual
-1.75
Earnings History > 31 > eps Estimate
0
Earnings History > 31 > eps Difference
-1.75
Earnings History > 31 > surprise Percent
-
Earnings History > 32 > period
2017-12-31
Earnings History > 32 > report Date
2018-03-07
Earnings History > 32 > date
2017-12-31
Earnings History > 32 > before After Market
-
Earnings History > 32 > currency
USD
Earnings History > 32 > eps Actual
0.02
Earnings History > 32 > eps Estimate
0
Earnings History > 32 > eps Difference
0.02
Earnings History > 32 > surprise Percent
-
MeiraGTx Holdings plc, a clinical stage genetics medicines company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases; neurodegenerative diseases; and xerostomia. It is also developing AAV-AQP1 in Phase 2 trial for radiation-induced grade 2/3 radiation-induced xerostomia, as well as in Phase ½ trial for Sjogren's syndrome; AAV-GAD in Phase 2 trial for Parkinson's disease; AAV-RPE65 in Phase 2 trial for RPE65-associated retinal dystrophy; and AAV-CNGB3 and AAV-CNGA3, which are both in Phase 2 trial for achromatopsia, as well as offers AAV-AIPL1 for Leber congenital amaurosis (LCA) 4. In addition, the company's products under preclinical development include AAV-RDH12 for retinol dehydrogenase 12 mutation-associated retinal dystrophy; AAV-BBS10 for Bardet-Biedl syndrome (BBS) due to BBS10 mutations; AAV-RetGC for LCA type 1; and AAV-UPF1 for amyotrophic lateral sclerosis, as well as programs for Alzheimer's disease, and wet and dry neovascular age related macular degeneration. Further, it provides riboswitch platform for the delivery of metabolic peptides; and cell therapies for oncology, autoimmune disease, and long term intractable pain. The company has collaborations with Johnson & Johnson Innovative Medicine for the research, development, and commercialization of gene therapies for the treatment of inherited retinal disease; and Hologen Limited for the research, development, manufacture, and commercialization of AAV-GAD investigational gene therapy for the treatment of Parkinson's disease, AAV-BDNF investigational gene therapy for genetic obesity disorders, and other genetic medicines to the central nervous system. MeiraGTx Holdings plc was founded in 2015 and is based in New York, New York.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AMeiraGTx Holdings plc (NASDAQ:MGTX) has caught the attention of institutional investors who hold a sizeable 31% stake Yahoo Finance
Read more →Discipline and Rules-Based Execution in MGTX Response news.stocktradersdaily.com
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$27.5
Analyst Picks
Strong Buy
3
Buy
2
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 79.23% of the total shares of MeiraGTx Holdings PLC
1.
Perceptive Advisors LLC(15.6948%)
since
2025/06/30
2.
Sanofi(15.1624%)
since
2025/06/30
3.
Johnson & Johnson(8.2552%)
since
2025/06/30
4.
Adage Capital Partners Gp LLC(7.5013%)
since
2025/06/30
5.
Prosight Management, LP(5.7024%)
since
2025/06/30
6.
Rubric Capital Management LP(4.6322%)
since
2025/06/30
7.
BlackRock Inc(3.5581%)
since
2025/06/30
8.
683 Capital Management LLC(3.3438%)
since
2025/06/30
9.
J. Goldman & Co LP(2.5415%)
since
2025/06/30
10.
Knoll Capital Management LP(1.5538%)
since
2025/06/30
11.
iShares Russell 2000 ETF(1.2756%)
since
2025/08/31
12.
Erste Asset Management GmbH(0.9816%)
since
2025/06/30
13.
Millennium Management LLC(0.976%)
since
2025/06/30
14.
State Street Corp(0.848%)
since
2025/06/30
15.
22NW, LP(0.7291%)
since
2025/06/30
16.
Geode Capital Management, LLC(0.6931%)
since
2025/06/30
17.
Long Focus Capital Management, LLC(0.6523%)
since
2025/06/30
18.
Morgan Stanley - Brokerage Accounts(0.5648%)
since
2025/06/30
19.
Vanguard Group Inc(0.5229%)
since
2025/06/30
20.
Fidelity Small Cap Index(0.5207%)
since
2025/06/30
21.
iShares Biotechnology ETF(0.4046%)
since
2025/08/31
22.
Royal Bank of Canada(0.3777%)
since
2025/06/30
23.
iShares Russell 2000 Growth ETF(0.3417%)
since
2025/08/31
24.
Northern Trust Corp(0.3405%)
since
2025/06/30
25.
Royce Smaller-Companies Growth Svc(0.2697%)
since
2025/06/30
26.
Vanguard Russell 2000 ETF(0.2472%)
since
2025/07/31
27.
Vanguard Health Care ETF(0.1664%)
since
2025/07/31
28.
State St Russell Sm Cap® Indx SL Cl I(0.1478%)
since
2025/08/31
29.
Schwab Small Cap Index(0.1302%)
since
2025/07/31
30.
NT R2000 Index Fund - NL(0.1253%)
since
2025/06/30
31.
iShares Micro-Cap ETF(0.1175%)
since
2025/08/31
32.
iShares Russell 2000 Value ETF(0.1155%)
since
2025/08/31
33.
Galileo - Biotech Innovation Fund S USD(0.1095%)
since
2025/02/28
34.
NT R2000 Index Fund - DC - NL - 3(0.0999%)
since
2025/06/30
35.
Russell Inv Tax-Managed US Mid&Sm Cap S(0.0987%)
since
2025/07/31
36.
Nuveen Equity Index R6(0.0948%)
since
2025/07/31
37.
SPDR® Russell 2000 US Small Cap ETF(0.091%)
since
2025/08/31
38.
iShares Russell 2000 Small-Cap Idx Instl(0.0885%)
since
2025/07/31
39.
Russell 2500™ Index Fund F(0.0818%)
since
2025/06/30
40.
Nuveen Small Cap Blend Idx R6(0.075%)
since
2025/07/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.368
Date
2025-09-30
EPS Actual
-0.62
EPS Estimate
-0.5
EPS Difference
-0.12
Surprise Percent
-24%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.